abs118.txt	background		published	guidelines	do	not	address	what	the	minimum	incrementaldiagnostic	yield	(idy)	for	detection	of	dysplasia/cancer	is	required	over	thestandard	seattle	protocol	for	an	advanced	imaging	modality	(aim)	to	beimplemented	in	routine	surveillance	of	barrett's	esophagus	(be)	patients		weaimed	to	report	expert	practice	patterns	and	attitudes		specifically	addressingthe	minimum	idy	in	the	use	of	aims	in	be	surveillance	methods		an	international	group	of	be	experts	completed	an	anonymous	electronicsurvey	of	domains	relevant	to	surveillance	practice	patterns	and	use	of	aims		theevaluated	aims	were	conventional	chromoendoscopy	(cc)		virtual	chromoendoscopy(vc)		volumetric	laser	endomicroscopy	(vle)		confocal	laser	endomicroscopy	(cle)	and	wide-area	transepithelial	sampling	(wats3d)		responses	were	recorded	usingfive-point	balanced	likert	items	and	analyzed	as	continuous	variables	results		the	survey	response	rate	was	84%	(61/73)-41	us	and	20	non-us		expertswere	most	comfortable	with	and	routinely	use	vc	and	cc		and	least	comfortablewith	and	rarely	use	vle		cle		and	wats3d		experts	rated	data	from	randomizedcontrolled	trials	(1	4	±	0	9)	and	guidelines	(2	6	±	1	2)	as	the	two	mostinfluential	factors	for	implementing	aims	in	clinical	practice		the	minimum	idyof	aims	over	standard	biopsies	to	be	considered	of	clinical	benefit	was	lowestfor	vc	(15%		iqr	10-29%)	and	highest	for	vle	(30%		iqr	20-50%)		compared	to	usexperts		non-us	experts	reported	higher	use	of	cc	for	be	surveillance(p	<	0	001)	conclusion		these	results	should	inform	benchmarks	that	need	to	be	met	forguidelines	to	recommend	the	routine	use	of	aims	in	the	surveillance	of	bepatients	
